Authors: Jason Chang, DNP, ARNP-C Affiliations: AVYIA Corresponding Author/Contact: jason.chang@avyia.com Abstract AbstractMrs. Physicist Dreamer, a...
Read More
A recent randomized controlled trial (RCT) in New Zealand evaluating the R-107 oral ketamine formulation…
The Ketamine for Acute Depression and Suicidality (KADS) trial has emerged as a landmark study…
A small but powerful study of patients with both post-traumatic stress disorder (PTSD) and treatment-resistant…
A recent active-controlled trial using subcutaneous ketamine injections over four weeks has demonstrated strong efficacy…
A new large-scale trial conducted by researchers at the University of New South Wales (UNSW)…
Major depressive disorder (MDD) continues to be a leading cause of disability worldwide, affecting over…
In the landmark study A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients…
In the open-label clinical study Efficacy, safety, and durability of repeated ketamine infusions for comorbid…
In the double-blind clinical trial Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy…
